Industry Briefs
July 23, 1990
Volume 4, #15The Scientist July 23, 1990 INDUSTRY BRIEFS Date: July 23, 1990 Centocor Looks Ahead Anticipating Food and Drug Administration approval of Centoxin, potentially the first therapeutic drug based on mononoclonal antibody technology, Centocor Inc., has announced plans to triple the size of its workforce in Malvern, Pa., the 11-year-old firm's headquarters. The four-year expansion, financed in part by $10.5 million in low-interest state loans, would add 1,000 new jobs. M
